| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

* From the Department of Anesthesiology and Pain Management and
Section of Neurobiology, Physiology, and Behavior, University of California, Davis, Davis, California USA.
Address correspondence to: Joseph F. Antognini MD, TB-170, University of California, Davis, Davis, CA 95616 USA. Fax: 530-752-7807; E-mail: jfantognini{at}ucdavis.edu
| Abstract |
|---|
|
|
|---|
Methods: Goats were anesthetized with isoflurane and neck dissections performed which permitted cranial bypass. A laminectomy was made to allow microelectrode recording of lumbar dorsal horn neuronal activity. Isoflurane was maintained at 0.8 ± 0.1% to both head and torso throughout the study. During cranial bypass propofol was separately administered to the torso (1 mgkg1, n=7; 3.75 mgkg1, n=8) or cranial (0.04 mgkg1, n=7; 0.14 mgkg1, n=8) circulations.
Results: Propofol administered to the torso depressed dorsal horn neuronal responses to noxious stimulation: low dose: 500 ± 243 to 174 ± 240 impulsesmin-1 at one minute post-injection, P < 0.001; high dose: 478 ± 204 to 91 ± 138 impulsesmin-1 at one minute post-injection, P < 0.05). Propofol administered to the cranial circulation had no effect: low dose: 315 ± 150 to 410 ± 272 impulsesmin-1, P > 0.05; high dose: 462 ± 261 to 371 ± 196 impulsesmin-1, P > 0.05.
Conclusions: These data indicate that propofol has a direct depressant effect on dorsal horn neuronal responses to noxious stimulation, with little or no indirect supraspinal effect.
| Introduction |
|---|
|
|
|---|
Propofol has been reported to have no antinociceptive properties,7 or to be hyperalgesic.8 Kishikawa et al.6 showed that propofol depressed dorsal horn neuronal responses to innocuous tactile stimuli, but they did not determine effects on responses to noxious stimuli, as no wide-dynamic range (WDR) cells were studied. In another study from the same laboratory, Uchida et al.9 determined that propofol depressed dorsal horn neuronal responses to noxious stimuli, although few WDR cells were studied. Taken together, these studies suggest that propofol depresses dorsal horn neurons, but the relative contributions of spinal and supraspinal actions to the total depressant effect of propofol remain unclear. If propofol is associated with hyperalgesia, then its supraspinal action might be enhancement of dorsal horn cell activity. This might occur as the result of propofol ablating descending inhibition of dorsal horn neurons. We hypothesized that propofol, acting in the brain, would either enhance (hyperalgesia) or have no effect on dorsal horn neuronal responses to a noxious mechanical stimulus applied to the hindlimb.
| Methods |
|---|
|
|
|---|
After lumbar laminectomy, the spine was secured using four vertebral clamps. The dura was slit and a tungsten recording microelectrode (resistance . 10 m
, F. Haer, Inc., Brunswick, ME) was inserted into the lumbar dorsal horn (approximate L5 level) using a hydraulic microdrive (D. Kopf Instruments, Tujunga, CA). We sought neurons that had receptive fields that included the dew-claws and/or hoof of the hindlimb. Extracellular action potentials were amplified, displayed on an oscilloscope, and relayed to a personal computer for off-line analysis.12 Wide-dynamic range and nociceptive-specific type neurons were sought. We only studied units that exhibited reproducible responses to a standard noxious mechanical clamp stimulus (10-inch hemostat applied to the dew-claw or a hoof bulb for 10 sec). Dorsal horn neuronal activity was determined for one minute prior to, and for one minute after the onset of each stimulus, except in one animal that had high spontaneous activity, in which case we used the 10 sec period prior to, and the 10 sec period during, application of the noxious stimulus. Control responses were obtained by applying the stimulus 1-5 times (usually three); the interstimulus interval was five minutes. Propofol was administered (4 mgkg1 iv) and dorsal horn neuronal activity (evoked by the noxious clamp) determined 1, 5, 10 and 15 min after propofol injection. Blood samples were obtained at each stimulus (and in three animals at three minutes as well) and stored for later propofol analysis. End-tidal isoflurane was maintained at 0.8 ± 0.1% to the head and torso throughout the study.
After determination of the control response to propofol injection, heparin (4 mgkg1 iv, repeated 2 mgkg1 every 1-2 hr) was administered and a cannula placed into the carotid artery, and Y cannulae were placed into the jugular veins. Blood (500 ml) was drained from the animal to prime the bubble oxygenator (B-10, Bentley, American Edwards, Irvine Ca). Oxygenator gas flow was O2 95% and CO2 5% at 5-6 Lmin1. An isoflurane vaporizer was placed in-line with the gas flow. Isoflurane concentration in the arterial blood perfusing the head and brain was estimated from the isoflurane concentration in the oxygenator exhaust,1,10 and torso isoflurane was determined from end-tidal sampling. Oxygenator exhaust and end-tidal gases were monitored with a calibrated agent analyzer. Cranial bypass was initiated by diverting cranial venous blood to the oxygenator, with cranial blood flow initiated at 250-500 mlmin1. The remaining open carotid artery was clamped to achieve complete bypass.1,10 Glucose was infused (10-20 mgmin1) into the oxygenator. Adequacy of cranial bypass was determined indirectly by monitoring the electroencephalogram (A-1050, Aspect Medical Systems, Natick, MA). Once bypass flows had stabilized (usually requiring about 30 min) spontaneous and evoked dorsal horn neuronal activities were recorded with cranial and torso isoflurane at 0.8 ± 0.1%. In three animals, initiation of bypass resulted in loss of the recorded neurons, and new neurons were found. (These three animals had pre-bypass responses similar to the other animals in which the ability to record neuronal responses was not lost.) Neuronal responses to the noxious clamp were determined and propofol administered to the cranial and torso circulations. Propofol was intravenously administered to the torso in low (1 mgkg1, n=7) and high (4 mgkg1, and one animal given 2 mgkg1, n=8) doses. The higher dose is a typical induction dose for goats.13 Propofol was administered to the venous limb of the oxygenator in low (0.025-0.05 mgkg1, mean 0.04 mgkg1, n=7) and high (0.1-2 mgkg1, mean 0.14 mgkg1, n=8) doses. The order of the propofol injections was varied experiment to experiment. In one animal, only the high propofol doses to head and torso were administered. Neuronal responses to the noxious mechanical clamp were determined at 1, 5, 10 and 15 min after each propofol injection. At each time point (and in three animals at three minutes as well) blood (5 ml) was withdrawn from the torso and cranial arterial circulations for later analysis of propofol concentrations. The individual propofol injections to the cranial and torso circulations were separated by at least 30-45 min to permit return of control neuronal responses and propofol concentrations in the torso and oxygenator blood to decrease to very low concentrations.
Because propofol administration to the torso resulted in transient blood pressure decreases, phenylephrine was administered to maintain blood pressure in the normal range. Phenylephrine was chosen because it does not appear to alter dorsal horn neuronal responses.14,15 Nonetheless, in four animals, we determined what effect, if any, phenylephrine had on neuronal responses. To evaluate possible effects of hypotension, in four animals we used nitroprusside, nitroglycerin and/or phentolamine to decrease the blood pressure to levels associated with propofol administration. The effects of phenylephrine and the hypotensive agents were tested at the peak of the hemodynamic response (generally at around one minute). The peak effect of propofol on blood pressure and dorsal horn neuronal responses also generally occurred at one minute. In five animals we also determined if the propofol vehicle (lipid emulsion) had any effect on neuronal responses.
The spinal recording site was marked with an electrolytic lesion by passing direct current through the recording microelectrode. The goat was killed with potassium chloride and isoflurane. The cord was removed, fixed in formalin, frozen, cut in 50 µm sections, and mounted on microscope slides. The electrolytic lesions were observed under a light microscope and plotted onto a computer video image of the spinal cord section.
Propofol concentration in blood was determined using high-pressure liquid chromatography (HPLC) with a protocol modified from two prior methods.16,17 In brief, after centrifuging, the plasma was stored at 70°C until analysis. The propofol was extracted from the plasma using a solid-phase extraction column and injected onto a Waters HPLC column (electrochemical detection). Using a range of 0-20 µgml1, standard curves were constructed that demonstrated high correlation coefficients r = 0.98-1.0). The lower limit of detection was 25 ngml1. To determine the propofol concentrations, the propofol peaks of the experimental samples were compared to the standard curves.
The data are expressed as mean ± standard deviation. Because the neuronal response data did not appear to be normally distributed, a log transformation was performed.18 Repeated measures analysis of variance (ANOVA) of the transformed data was used to detect differences in neuronal responses pre- vs post-propofol injection, followed by the Student-Newman-Keuls multiple comparisons test. A P < 0.05 was considered to be statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Although the exact site at which propofol acts is unknown, there is mounting evidence that the GABAA receptor modulates, at least in part, propofol's effects.23 The GABAA antagonists (bicuculline and SR-95531) partially reverse the antinociceptive effect of propofol.24 Interestingly, opiate-receptor antagonism also reverses propofol's antinociceptive effect, so the relative roles of the GABAA and opiate receptors in propofol's action remain unclear.24 Propofol also appears to act on sodium channels.25
In our previous study, we determined that isoflurane, similar to propofol, had predominately direct spinal effects.26 In the present study, we recorded neuronal responses during isoflurane administration (0.8%). It is possible that this isoflurane concentration might have masked any subtle effects of propofol. Studies that documented supraspinal descending inhibition of dorsal horn neurons were performed in anesthetized animals.27,28 Despite the presence of sufficient anesthesia to block nocifensive reflexes, descending modulation still occurred.27,28 For example, administration of small doses of pentobarbital reduced tonic descending inhibition in monkeys anesthetized with chloralose supplemented by pentobarbital.29 Thus, had there been any indirect supraspinal depressive effect of propofol, we should have detected it, although it was likely small compared to the overwhelming direct spinal effect. Furthermore, because we used anesthetic doses, we cannot make any conclusions about effects due to sub-hypnotic propofol doses. Our experimental protocol (baseline isoflurane anesthesia with propofol injection) has application to the clinical situation in which an isoflurane-anesthetized patient moves and propofol is administered to stop the movement.
The peak propofol concentration in the head (following the high dose) did not match the peak occurring after the high dose administered to the torso. The low torso dose, however, depressed the dorsal horn neuronal response to the same degree as the high torso dose. Thus, the maximal direct effect was reached with a peak plasma concentration of 2 µgml1. Because the peak cranial concentration with the high cranial dose was 4.5 µgml1, it seems unlikely that we would have missed a large indirect depressive effect. The areas under the curves were similar so that cranial and torso injection of propofol resulted in similar probabilities for propofol to access its sites of action. We cannot discount the possibility that some dorsal horn neurons might have been affected by cranial propofol administration inasmuch as not all dorsal horn neurons are necessarily similarly affected by supraspinal actions of propofol (e.g., some neurons, but not all, might be modulated by propofol's supraspinal effects).
Propofol when selectively administered to the cranial circulation had no effect on dorsal horn neuronal responses to noxious mechanical stimulation, while torso administration markedly depressed these responses. These data indicate that propofol, in anesthetic doses, directly depresses neurons in the dorsal horn, with minimal indirect supraspinal effects.
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Accepted for publication December 5, 1999.
| References |
|---|
|
|
|---|
2 Rampil IJ. Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 1994; 80: 60610.[Medline]
3 Willis WD, Westlund KN. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 1997; 14: 231.[Medline]
4 Namiki A, Collins JG, Kitahata LM, Kikuchi H, Homma E, Thalhammer JG. Effects of halothane on spinal neuronal responses to graded noxious heat stimulation in the cat. Anesthesiology 1980; 53: 47580.[Medline]
5 de Jong RH , Robles R, Heavner JE. Suppression of impulse transmission in the cat's dorsal horn by inhalation anesthetics. Anesthesiology 1970; 32: 4405.[Medline]
6
Kishikawa K, Uchida H, Yamamori Y, Collins JG. Low-threshold neuronal activity of spinal dorsal horn neurons increases during REM sleep in cats: comparison with effects of anesthesia. J Neurophysiol 1995; 74: 7639.
7 Grounds RM, Lalor JM, Lumley J, Royston D, Morgan M. Propofol infusion for sedation in the intensive care unit: preliminary report. BMJ 1987; 294: 397400.
8
Ewen A, Archer DP, Samanani N, Roth SH. Hyperalgesia during sedation: effects of barbiturates and propofol in the rat. Can J Anaesth 1995; 42: 53240.
9 Uchida H, Kishikawa K, Collins JG. Effect of propofol on spinal dorsal horn neurons. Comparison with lack of ketamine effects. Anesthesiology 1995; 83: 131222.[Medline]
10 Antognini JF, Kien ND. A method for preferential delivery of volatile anesthetics to the in situ goat brain. Anesthesiology 1994; 80: 114854.[Medline]
11
Antognini JF, Jinks S, Buzin V, Carstens E. A method for differential delivery of intravenous drugs to the head and torso of the goat. Anesth Analg 1998; 87: 14502.
12 Forster C, Handwerker HO. Automatic classification and analysis of microneurographic spike data using a PC/AT. J Neurosci Methods 1990; 31: 10918.[Medline]
13 Reid J, Nolan AM, Welsh E. Propofol as an induction agent in the goat: a pharmacokinetic study. J Vet Pharmacol Ther 1993; 16: 48893.[Medline]
14 Fleetwood-Walker SM, Mitchell R, Hope PJ, Molony V, Iggo A. An 2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Res 1985; 334: 24354.[Medline]
15 Davies J, Quinlan JE. Selective inhibition of responses of feline dorsal horn neurones to noxious cutaneous stimuli by tizanidine (DS103-282) and noradrenaline: involvement of 2-adrenoceptors. Neuroscience 1985; 16: 67382.[Medline]
16 Mazzi G, Schinella M. Simple and practical high-performance liquid chromatographic assay of propofol in human blood by phenyl column chromatography with electrochemical detection. J Chromatogr A 1990; 528: 53741.
17 Chan K, So APC. The measurement of propofol in human blood samples by liquid chromatography. Meth Find Exp Clin Pharmacol 1990; 12: 1359.[Medline]
18 Zar JH. Biostatistical Analysis, 4th ed. Upper Saddle River, NJ: Prentice-Hall, 1999: 27381.
19 Jewett BA, Gibbs LM, Tarasiuk A, Kendig JJ. Propofol and barbiturate depression of spinal nociceptive neurotransmission. Anesthesiology 1992; 77: 114854.[Medline]
20
Petersen-Felix S, Arendt-Nielsen L, Bak P, Fisher M, Zbinden AM. Psychophysical and electrophysiological responses to experimental pain may be influenced by sedation: comparison of the effects of a hypnotic (propofol) and an analgesic (alfentanil). Br J Anaesth 1996; 77: 16571.
21
Anker-Møller E, Spangsberg N, Arendt-Nielsen L, Schultz P, Kristensen MS, Bjerring P. Subhypnotic doses of thiopentone and propofol cause analgesia to experimentally induced acute pain. Br J Anaesth 1991; 66: 1858.
22 Wilder-Smith OHG, Kolletzki M, Wilder-Smith CH. Sedation with intravenous infusions of propofol or thiopentone. Effects on pain perception. Anaesthesia 1995; 50: 21822.[Medline]
23
Sanna E, Mascia MP, Klein RL, Whiting PJ, Biggio G, Harris RA. Actions of the general anesthetic propofol on recombinant human GABAA receptors: influence of receptor subunits. J Pharmacol Exp Ther 1995; 274: 35360.
24 Nadeson R, Goodchild CS. Antinociceptive properties of propofol: involvement of spinal cord aminobutyric acidA receptors. J Pharmacol Exp Ther 1997; 283: 11816.
25 Rehberg B, Duch DS. Suppression of central nervous system sodium channels by propofol. Anesthesiology 1999; 91: 51220.[Medline]
26
Jinks S, Antognini JF, Carstens E, Buzin V, Simons C. Isoflurane can indirectly depress lumbar dorsal horn activity in the goat via action within the brain. Br J Anaesth 1999; 82: 2449.
27 Carstens E, Gilly H, Schreiber H, Zimmermann M. Effects of midbrain stimulation and iontophoretic application of serotonin, noradrenaline, morphine and GABA on electrical thresholds of afferent C- and A-fibre terminals in cat spinal cord. Neuroscience 1987; 21: 395406.[Medline]
28 Carstens E. Inhibition of rat spinothalamic tract neuronal responses to noxious skin heating by stimulation in midbrain periaqueductal gray or lateral reticular formation. Pain 1988; 33: 21524.[Medline]
29 Hori Y, Lee KH, Chung JM, Endo K, Willis WD. The effects of small doses of barbiturate on the activity of primate nociceptive tract cells. Brain Res 1984; 307: 915.[Medline]
This article has been cited by other articles:
![]() |
L. S. Barter, L. O. Mark, S. L. Jinks, E. E. Carstens, and J. F. Antognini Immobilizing Doses of Halothane, Isoflurane or Propofol, Do Not Preferentially Depress Noxious Heat-Evoked Responses of Rat Lumbar Dorsal Horn Neurons with Ascending Projections Anesth. Analg., March 1, 2008; 106(3): 985 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guindon, J. LoVerme, D. Piomelli, and P. Beaulieu The Antinociceptive Effects of Local Injections of Propofol in Rats Are Mediated in Part by Cannabinoid CB1 and CB2 Receptors Anesth. Analg., June 1, 2007; 104(6): 1563 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Merrill, L. S. Barter, U. Rudolph, E. I. Eger II, J. F. Antognini, M. I. Carstens, and E. Carstens Propofol's effects on nociceptive behavior and spinal c-fos expression after intraplantar formalin injection in mice with a mutation in the gamma-aminobutyric acid-type(A) receptor beta3 subunit. Anesth. Analg., August 1, 2006; 103(2): 478 - 83, table of contents. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mitsuyo, J. F. Antognini, and E. Carstens Etomidate depresses lumbar dorsal horn neuronal responses to noxious thermal stimulation in rats. Anesth. Analg., April 1, 2006; 102(4): 1169 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Inoue, M. Kawaguchi, M. Takahashi, M. Kakimoto, T. Sakamoto, K. Kitaguchi, H. Furuya, T. Morimoto, and T. Sakaki Noxious stimuli do not modify myogenic motor evoked potentials by electrical stimulation during anesthesia with propofol-based anesthesia: [Des stimuli douloureux ne modifient pas les potentiels evoques myogenes moteurs obtenus par stimulation electrique pendant l'anesthesie a base de propofol] Can J Anesth, January 1, 2003; 50(1): 86 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kendig In vitro networks: subcortical mechanisms of anaesthetic action Br. J. Anaesth., July 1, 2002; 89(1): 91 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vahle-Hinz and O. Detsch What can in vivo electrophysiology in animal models tell us about mechanisms of anaesthesia? Br. J. Anaesth., July 1, 2002; 89(1): 123 - 142. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |